Overview

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by open-label naturalistic follow-up.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Citalopram
Dexetimide
Duloxetine Hydrochloride